Interventions for treating iron deficiency anaemia in inflammatory bowel disease-Reference-Cited by-同舟云学术

Interventions for treating iron deficiency anaemia in inflammatory bowel disease

Published:2021-01-20 Issue:1 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gordon Morris¹,Sinopoulou Vassiliki¹,Iheozor-Ejiofor Zipporah²,Iqbal Tariq³,Allen Patrick⁴,Hoque Sami⁵,Engineer Jaina⁶,Akobeng Anthony K⁷

Affiliation:

1. School of Medicine; University of Central Lancashire; Preston UK

2. Cochrane Bone Joint and Muscle Trauma Group; Centre for Musculoskeletal Research, Institute of Inflammation and Repair, The University of Manchester; Manchester UK

3. Queen Elizabeth Hospital; Birmingham UK

4. Department of Gastroenterology and Hepatology; Ulster Hospital; Belfast Ireland

5. Barts Health NHS Trust; London UK

6. Crohn’s and Colitis UK; Hatfield UK

7. Sidra Medicine; Doha Qatar

Publisher

Wiley

Subject

Pharmacology (medical)

Reference137 articles.

1. Effects of ferrous sulphate and non-ionic iron-polymaltose complex onmarkers of oxidative tissue damage in patients with inflammatory bowel disease;Erichsen;Alimentary Pharmacology and Therapeutics,2005

2. Oral ferrous fumarate or intravenous iron sucrosefor patients with inflammatory bowel disease;Erichsen;Journal of Gastroenterology,2009

3. A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus iron sucrose (VENOFER®) for treatment of iron deficiency anaemia in patients with inflammatory bowel disease clinicaltrialsregister.eu/ctr-search/trial/2008-002333-75/results

4. FERGIcor, a randomized controlled trial on ferric carboxymaltose forIron deficiency anemia in inflammatory bowel disease;Evstatiev;Gastroenterology,2011

5. Intravenously administered ferric carboxymaltose and iron sucrose significantly improve quality of life in patients with IBD-associated iron deficiency anaemia;Evstatiev;Journal of Crohns and Colitis,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Selection of parenteral iron supplement for iron deficiency anemia: A review;Terapevticheskii arkhiv;2024-05-02

3. Parenteral Iron Therapy for Pediatric Patients;Hemato;2024-01-19

4. Anemia and iron deficiency in pregnant women with rheumatic diseases;Joint Bone Spine;2024-01

5. Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol;BMJ Open;2024-01